PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer

類似資料

• Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer
  著者:: Alfarsi, Lutfi H., 等
  出版事項: (2020)
• Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer
  著者:: Alfarsi, Lutfi H., 等
  出版事項: (2020)
• The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
  著者:: El Ansari, Rokaya, 等
  出版事項: (2020)
• Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer
  著者:: Ansari, Rokaya El, 等
  出版事項: (2019)
• SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer
  著者:: Lutfi H. Alfarsi, 等
  出版事項: (2025-01-01)